IPP Bureau
BioAge appoints former GSK CEO Jean-Pierre Garnier as Chair of its Board of Directors
By IPP Bureau - August 23, 2024
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Pfizer and BioNTech receive FDA authorization for Omicron KP.2-adapted Covid-19 Vaccine
By IPP Bureau - August 23, 2024
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
Roche responds to WHO’s declaration of health emergency due to mpox outbreak
By IPP Bureau - August 23, 2024
Roche confirms that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants
Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target
By IPP Bureau - August 23, 2024
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Sun Pharma introduces STARIZO in India for skin infections
By IPP Bureau - August 23, 2024
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
Novartis and Versant to form biotech venture Borealis Biosciences
By IPP Bureau - August 23, 2024
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
Lupin receives Health Canada approval for biosimilar Pegfilgrastim
By IPP Bureau - August 23, 2024
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
Wanbury receives EIR from FDA for Patalganga facility
By IPP Bureau - August 23, 2024
USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation
HearClear partners with Neuberg Diagnostics to create integrated hearing care ecosystem
By IPP Bureau - August 23, 2024
The brand will establish an integrated hearing care ecosystem at Neuberg Diagnostics centers across the length and breadth of the country
Nephro Care India reports 86.07% jump in PAT at Rs 4.41 crore during FY 23-24
By IPP Bureau - August 23, 2024
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
Balancing wellness and waste: sustainable solutions for medical packaging: MHolland
By IPP Bureau - August 22, 2024
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Wanbury bags safety awards for its API manufacturing site in Patalganga
By IPP Bureau - August 22, 2024
These accolades highlight our unwavering commitment to maintaining the highest safety standards
Aster DM Healthcare launches Tele ICU Services in India
By IPP Bureau - August 22, 2024
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
Mangalam Drugs & Organics expanding anti-malaria APl portfolio with introduction of Pyronaridine
By IPP Bureau - August 21, 2024
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Wanbury appoints Pradeep Patni as CEO of India Formulation Business
By IPP Bureau - August 21, 2024
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
